NasdaqGS:CYTKBiotechs
Cytokinetics (CYTK) Valuation Check After Recent Share Price Moves And Aficamten Expectations
Cytokinetics stock overview
Cytokinetics (CYTK) has drawn fresh attention after recent share price moves, prompting investors to reassess how its late stage muscle focused drug pipeline and current financial profile line up with their risk appetite.
See our latest analysis for Cytokinetics.
At a share price of $62.34, Cytokinetics has seen a 3.49% 1 day share price return but softer recent momentum, with a 90 day share price return decline of 6.26%. However, the 1 year total shareholder...